NashatGabrailMD

Clinical Trials

• Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01

  Unknown status

  Phase 4

• Safety and Efficacy Study of Glufosfamide in Ovarian Cancer Start of enrollment: 2007 Jan 01

  Terminated

  Phase 2

• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Start of enrollment: 2011 Jan 16

  Completed

  Phase 3

• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01

  Completed

  Phase 3

• Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01

  Terminated

  Phase 3

• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20

  Completed

  Phase 3

• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma Start of enrollment: 2012 Jun 03

  Completed

• Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01

  Terminated

  Phase 2, Phase 3

• Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  RECRUITING

  PHASE3

• Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Feb 05

  Terminated

  Phase 3

• Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion Start of enrollment: 2014 Aug 06

  Terminated

  Phase 2

• ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases Start of enrollment: 2014 Apr 01

  Completed

  Phase 2

• Selinexor (KPT-330) in Older Patients With Relapsed AML Start of enrollment: 2014 Mar 01

  Completed

  Phase 2

• Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01

  Terminated

  Phase 2

• A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC Start of enrollment: 2014 Mar 01

  Completed

  Phase 3

• A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer Start of enrollment: 2014 Jul 01

  Terminated

  Phase 2

• Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL Start of enrollment: 2014 Jun 01

  Terminated

  Phase 2

• KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors Start of enrollment: 2014 Aug 01

  Completed

  Phase 2

• CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) Start of enrollment: 2015 Aug 01

  Completed

  Phase 1, Phase 2

• OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure Start of enrollment: 2016 Feb 12

  Terminated

  Phase 3

• To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment. Start of enrollment: 2016 Mar 01

  Terminated

  Phase 1

• Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy Start of enrollment: 2016 Apr 12

  Completed

  Phase 1

• Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes Start of enrollment: 2016 Apr 27

  Completed

  Phase 1

• A Study of Mitoxantrone Hydrochloride Liposome Infusion Start of enrollment: 2016 Aug 01

  Unknown status

  Phase 1, Phase 2

• TR(ACE) Assay Clinical Specimen Study Start of enrollment: 2016 Sep 01

  Unknown status

• A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies Start of enrollment: 2017 Feb 08

  Terminated

  Phase 1, Phase 2

• A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2016 Dec 28

  Completed

  Phase 2

• A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors Start of enrollment: 2018 Dec 13

  Recruiting

  Phase 1, Phase 2

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement Start of enrollment: 2023 Jul 05

  RECRUITING

  PHASE2

  Roles: Principal Investigator

• Join now to see all